| Product Code: ETC8836467 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The bradykinin-mediated angioedema market is niche but growing as diagnosis and awareness improve in the Philippines. Advances in targeted therapies and the availability of newer treatments are helping to improve patient outcomes.
The bradykinin-mediated angioedema market in the Philippines is growing due to the increasing diagnosis and awareness of this rare but serious condition. Bradykinin-mediated angioedema is characterized by recurrent episodes of swelling, and patients require treatment to prevent or manage attacks. The market is driven by the development of new therapeutic options, including drugs that target the bradykinin pathway, offering effective treatment for patients suffering from this condition. As healthcare providers become more aware of bradykinin-mediated angioedema, the market for its treatment is likely to see continued growth.
The bradykinin-mediated angioedema market faces challenges due to limited awareness among both healthcare providers and patients, as well as difficulties in accurately diagnosing the condition. The availability of specific treatments is limited, and the cost of medications remains high, which may prevent patients from accessing necessary therapies. Additionally, the conditions rarity makes it difficult for healthcare professionals to gain experience with appropriate treatment regimens.
The Philippines Bradykinin Mediated Angioedema Market is seeing growth with the rising incidence of this rare condition, which involves swelling due to an overactive bradykinin response. As awareness of angioedema increases, there is greater demand for effective treatments. Investment opportunities lie in developing targeted therapies that address the underlying causes of the disease, as well as improving diagnostic tools to identify cases earlier and provide timely treatments.
Government policy around bradykinin-mediated angioedema focuses on drug regulation, safety, and access. The FDA ensures that therapies, including novel biologics, meet rigorous standards before approval. Meanwhile, the DOH works to improve patient access through public hospital programs and integration of rare disease treatments into national health plans. The Rare Disease Act of the Philippines also supports this market by promoting early diagnosis and financial support for affected patients.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Bradykinin Mediated Angioedema Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Bradykinin Mediated Angioedema Market - Industry Life Cycle |
3.4 Philippines Bradykinin Mediated Angioedema Market - Porter's Five Forces |
3.5 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.7 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Philippines Bradykinin Mediated Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about bradykinin mediated angioedema in the Philippines |
4.2.2 Advances in diagnostic technologies for early detection |
4.2.3 Growing investments in healthcare infrastructure and services |
4.3 Market Restraints |
4.3.1 Limited access to specialized treatment centers in remote areas |
4.3.2 High cost associated with treatment and medications |
4.3.3 Lack of trained healthcare professionals in managing bradykinin mediated angioedema cases |
5 Philippines Bradykinin Mediated Angioedema Market Trends |
6 Philippines Bradykinin Mediated Angioedema Market, By Types |
6.1 Philippines Bradykinin Mediated Angioedema Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By C1-INH Concentrates, 2021- 2031F |
6.1.4 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Bradykinin B2-Receptor Antagonist, 2021- 2031F |
6.1.5 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Icatibant, 2021- 2031F |
6.1.6 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Kallikrein Inhibitor, 2021- 2031F |
6.1.7 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Ecallantide, 2021- 2031F |
6.1.8 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Bradykinin Mediated Angioedema Market, By Mode of Administration |
6.2.1 Overview and Analysis |
6.2.2 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.3 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.4 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Philippines Bradykinin Mediated Angioedema Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.4 Philippines Bradykinin Mediated Angioedema Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Philippines Bradykinin Mediated Angioedema Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Bradykinin Mediated Angioedema Market Import-Export Trade Statistics |
7.1 Philippines Bradykinin Mediated Angioedema Market Export to Major Countries |
7.2 Philippines Bradykinin Mediated Angioedema Market Imports from Major Countries |
8 Philippines Bradykinin Mediated Angioedema Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis |
8.2 Number of healthcare facilities offering specialized care for bradykinin mediated angioedema |
8.3 Patient adherence to prescribed treatment regimens |
8.4 Rate of complications or hospitalizations due to bradykinin mediated angioedema |
9 Philippines Bradykinin Mediated Angioedema Market - Opportunity Assessment |
9.1 Philippines Bradykinin Mediated Angioedema Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Philippines Bradykinin Mediated Angioedema Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.3 Philippines Bradykinin Mediated Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Philippines Bradykinin Mediated Angioedema Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Philippines Bradykinin Mediated Angioedema Market - Competitive Landscape |
10.1 Philippines Bradykinin Mediated Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Philippines Bradykinin Mediated Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here